Budding yeast Cdc48 is an essential, highly abundant member of the AAA (ATPase associated with various cellular activities) protein family. Cdc48 has been linked to numerous functions throughout the cell but is best known for its critical role in ERAD (endoplasmic reticulum associated protein degradation)[^1^](#G1){ref-type="fn"}, which occurs via the ubiquitin proteasome system (UPS). It is also involved in cell-cycle progression, homotypic membrane fusion, chromatin remodeling, autophagy, and transcriptional and metabolic regulation ([@B1][@B2][@B3]--[@B4]). Human Cdc48, known as p97 or VCP, has been the subject of much attention over the last few years because of its causal links to amyotrophic lateral sclerosis and inclusion body myopathy, Paget\'s disease of the bone, and frontotemporal dementia as well as its implied role in a variety of diseases including cancer ([@B5][@B6][@B7][@B8]--[@B9]). As a result, p97 has been the target of multiple drug development efforts ([@B10], [@B11]).

Cdc48/p97 interacts with a large number of putative substrate adaptors and cofactors, including a family of proteins (seven in yeast, 13 in human cells) that contain a UBX domain ([@B12], [@B13]). The UBX domain binds to the N-terminal region of p97 and proteins bearing this domain have been suggested to serve as interchangeable adaptors that target Cdc48/p97 to specific substrates. Although the functions and mechanism of action of Cdc48/p97 remain poorly understood, it is generally presumed that it uses ATP hydrolysis to fuel the extraction of ubiquitinated proteins from multisubunit complexes or membranes as a prelude to their degradation by the proteasome. Cdc48/p97 may also remodel protein--protein and protein--nucleic acid complexes in a manner that is not coupled to either prior ubiquitination ([@B14]) or subsequent degradation by the proteasome ([@B15], [@B16]).

Based on the abundance of Cdc48/p97 and the complexity of the network of adaptor proteins for which it serves as the hub, Cdc48/p97 has the potential to exert a profound influence on the UPS. However, the number of known substrates of Cdc48/p97 remains relatively small, and smaller still is the number of substrates that have been linked to a specific UBX domain protein. Indeed, only a handful of specific cases are known, and in half of them proteasomal degradation is not the final outcome ([@B15][@B16][@B17][@B18][@B19][@B20][@B21]--[@B22]). To understand why there is such a profusion of UBX domain proteins in cells, it will be important to determine what these proteins do to their substrates, which will require knowing what their substrates are. Therefore, a major goal of this work was to enable future investigations into the function and regulation of UBX proteins by assembling a catalogue of candidate substrates/targets.

A key paradigm that guides our current understanding of Cdc48 function emerged from studies on the processing of the transcription factors Spt23 and Mga2 ([@B23][@B24]--[@B25]). These seminal studies revealed the mechanism by which cells control their ratio of saturated to unsaturated fatty acids to maintain an appropriate lipid composition in cellular membranes. Central to this regulation are the transcription factors Spt23 and Mga2, which are released from the endoplasmic reticulum (ER) membrane and translocate to the nucleus to activate expression of *OLE1*, which encodes the stearoyl-Δ9 desaturase that governs the conversion of saturated fatty acids (SFAs) to unsaturated fatty acids (UFAs) ([@B26], [@B27]). Spt23 and Mga2 are initially produced as 120 kDa precursors (p120) embedded in the ER by C-terminal signal or anchor domains, such that the bulk of each protein projects into the cytosol. The p120 form of each protein is ubiquitinated by Rsp5 and cleaved by the proteasome, which yields a p90 form that lacks the transmembrane signal or anchor ([@B23], [@B25], [@B28][@B29]--[@B30]). However, p90 remains tethered to the ER through dimerization to an uncleaved p120, until it is disengaged from its partner by the "segregase" activity of Cdc48, acting in concert with Ufd1-Npl4 ([@B24], [@B31], [@B32]). The released p90 can then travel to the nucleus, where it activates expression of *OLE1* ([@B24]). The p90 species are quite unstable, and Cdc48 also promotes their degradation ([@B33]). In addition to acting as a transcription factor, Mga2 also influences the stability of *OLE1* mRNA ([@B34]), although the degree to which this function is carried out by p90 or p120 is not understood.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Yeast Strains and Growth Conditions

Strains, plasmids, and primers used in this study are described in [supplemental Tables S3--S5](http://www.mcponline.org/cgi/content/full/M113.030163/DC1). All yeast strains are derivates of either the wild-type strain RJD 4614 (S288C background from the OpenBiosystems Yeast Knockout Library) or the wild-type strain RJD 360 (W303 background). For Ubx2 domain analysis experiments, mutants were derived from strains gifted by Chao-Wen Wang. Standard genetic techniques were used. Unless otherwise stated, strains were grown at 30 °C and cultured in yeast extract/peptone/dextrose (YPD).

#### SILAC Labeling of Cells

For SILAC experiments, strains auxotrophic for lysine and arginine were used. Cells expressing ^His8^ubiquitin were grown in complete synthetic medium with 2% dextrose containing 20 mg/L lysine and arginine or in "heavy" medium with 20 mg/L ^13^C~6~^15^N~2~-lysine and ^13^C~6~-arginine (Cambridge Isotope Laboratories, Andover, MA). All mutant strains with the exception of *cdc48--3* and *ubx2*Δ expressed ^His8^ubiquitin and endogenous ubiquitin in a 1:1 ratio. *Cdc48--3* and *ubx2Δ cells* expressed lower levels of ^His8^ubiquitin, which we corrected for during quantification. Cells were grown for 10 generations to log-phase (OD~600~ 1.0--2.0) and equal amounts of the light and heavy-labeled cells (as determined by OD~600~) were mixed, harvested, washed, and flash frozen.

#### Purification of Ub Conjugates

Purifications were performed similarly to the protocol described previously ([@B35]). Two hundred OD~600~ units of cells were lysed in urea buffer (8 [m]{.smallcaps} urea, 300 m[m]{.smallcaps} NaCl, 100 m[m]{.smallcaps} Na~2~PO~4~, 10 m[m]{.smallcaps} Tris-HCl pH 8.0, 0.2% Triton X-100, 20 m[m]{.smallcaps} imidazole, and 5 m[m]{.smallcaps} N-ethylmaleimide (NEM)) by vortexing with glass beads. Ubiquitinated proteins were purified by the addition of nickel-NTA bead slurry (50 μl beads/5-10 mg of lysate) to clarified lysate (13,200 rpm for 15 min in an eppendorf Centrifuge 5417R) and mixed at room temperature for 90 min. Beads were washed three times with 20 bed volumes of buffer. A two-step digestion was performed directly on proteins bound to the beads by first digesting with Lys-C for 4 h, followed by overnight digestion with trypsin ([@B36]).

#### Fractionation and Liquid Chromatography-tandem MS (LC-MS/MS)

The tryptic peptides were desalted on a C18 macrotrap (Michrom Bioresources, Auburn, CA) and concentrated *in vacuo*. Dried samples were resuspended and subjected to StageTip-based strong anionic exchange (SAX) as previously described ([@B37]). Samples were eluted, concentrated, and then acidified before mass spectrometric analysis. Mass spectrometry experiments were performed on an EASY-nLC (Thermo Scientific) connected to a hybrid LTQ-Orbitrap Classic with a nanoelectrospray ion source (Thermo Scientific) using a setup and settings ([@B38]) very similar to those previously described ([@B39]). Binding and separation of the peptides took place on a 15 cm silica analytical column (75 μm ID) packed in-house with reversed phase ReproSil-Pur C~18AQ~ 3 μm resin (Dr Maisch GmbH, Ammerbuch-Entringen, Germany). Samples were run for 240 min on a 5% to 25% acetonitrile gradient in 0.2% formic acid at a flow rate of 350 nL per minute. The mass spectrometer was programmed to acquire data in a data-dependent mode, automatically switching between full-scan MS and tandem MS acquisition. Survey full scan MS spectra (from *m*/*z* 300 to 1700) were acquired in the Orbitrap after the accumulation of 500,000 ions, with a resolution of 60,000 at 400 *m*/*z*. The ten most intense ions were sequentially isolated, and after the accumulation of 5000 ions, fragmented in the linear ion trap by collision-induced dissociation (CID) (collisional energy 35% and isolation width 2 Da). Precursor ion charge state screening was enabled and singly charged and unassigned charge states were rejected. The dynamic exclusion list was set for a 90 s maximum retention time, a relative mass window of 10 ppm, and early expiration was enabled.

#### Mass Spec Analysis and Quantification

Thermo raw data files were analyzed by MaxQuant (v 1.3.0.5) ([@B40]) and were searched against the SGD yeast database (5911 sequences) and an in-house contaminant database (259 sequences) including human keratins and proteases. All default options were used except as follows: match between runs was enabled (2 min maximum), GlyGly on Lys (+114.042927), and multiplicity of 2 with heavy labels Arg6 (+6.020129) and Lys8 (+8.014199). Tryptic digest was specified with up to two missed cleavages. Initial precursor mass tolerance was 7 ppm, however MaxQuant calculates tighter individual precursor tolerances after recalibration. Fragment ion tolerance was 0.5 Da. Peptide, protein, and site false discovery rates were fixed at 1% using the target-decoy approach with a reversed database ([@B40]). The minimum number of peptides for quantification was 1. Spectra for the small number of proteins identified by a single peptide are included in the [supplemental Material](http://www.mcponline.org/cgi/content/full/M113.030163/DC1) section. Further data processing was performed to calculate ratios and standard errors of the ratios for each mutant using in-house scripts described previously ([@B41]). Briefly, hierarchical models are constructed for each mutant, in which the overall ratio for each protein is the geometric mean of the biological replicates and the biological replicate ratio is the median of all of the peptide ratios in the replicate. The standard error of the overall protein ratio is calculated by estimating the global peptide ratio standard error using pooled variance (calculated separately for peptide ratios based on requantified isotopic patterns) and using a bootstrapping procedure to resample at each level in the hierarchical model. In cases in which the protein replicate ratios are inconsistent (*i.e.* up-regulated in one sample and down-regulated in another), the standard error would be very large and the protein would not be considered significantly changed from 1:1.

To calculate a *p* value for the number of significantly elevated proteins in at least one experiment, a bootstrapping method was employed. For each bootstrapping iteration, the ratios observed were randomly reassigned to proteins. Next, the pooled variance was calculated based on these reassigned ratios and the hierarchical models were recomputed. Finally, we counted the number of proteins that were significantly elevated using the same criteria as with the real data. A thousand bootstrap iterations were calculated. In most bootstrap iterations, no proteins were found to be significantly elevated in any experiment. We then modeled the distribution of counts of significantly enriched proteins with a Poisson distribution.

All quantified proteins were used to construct [Figs. 1](#F1){ref-type="fig"}*B* and [supplemental Figs. S1*A*, S1*B*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1). Proteins for which the probability that they changed more than 10% in the WT/WT control experiment was \>99% or were not significantly enriched (*p* value ≥ 0.05) in the ^His8^Ub expressing cells compared with the untagged control cells were filtered out because of the high likelihood that they would yield false positive identifications in the mutant/wild type comparisons. Analyses relating to comparisons with the *Saccharomyces cerevisiae* ubiquitin database (SCUD) and the response of the ubiquitination enzymes in the *cdc48--3* mutant used all proteins not filtered out. All proteins not filtered out that were quantified in all mutants were used in the remaining bioinformatic analyses. In [Figs. 1](#F1){ref-type="fig"}*C* and [1](#F1){ref-type="fig"}*D*, we considered proteins to be significantly changed if there was a less than 1% chance that the fold change was less than 10% based on the individual protein standard error. Yeast GO-Slim annotations for [Figs. 2](#F2){ref-type="fig"}*A* and [2](#F2){ref-type="fig"}*B* were downloaded from the SGD. Proteins considered significantly enriched had a more than 10% change from 1:1 (*p* value \< 0.05). Annotations for [supplemental Fig. S3*A*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1) and [supplemental Figs. S4*A*-S4*E*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1) were downloaded from DAVID ([@B42], [@B43]). Displayed terms were deemed significantly different at a *p* value \< 0.05 (*e.g.* the 25th percentile of the ratios of the proteins annotated with the term was significantly greater than random) after correcting for multiple hypotheses testing using the Benjamini and Hochberg method(44).

#### Confirmation of Ub Conjugate Accumulation for Spt23

Ubiquitin conjugates were purified from 100 OD~600~ units of cells expressing tagged ubiquitin as described in the purification of Ub conjugates section. However after washing beads an equal volume of 2× SDS-PAGE buffer was added before boiling the beads for 5 min to elute conjugates. Boiled aliquots were resolved by SDS-PAGE and immunoblotted for endogenously tagged ^myc^Spt23^V5^.

#### Confirmation of Ub Conjugate Accumulation for Mga2

Cells (100 OD~600~ units) were disrupted using a FastPrep-24 in lysis buffer containing 50 m[m]{.smallcaps} Tris-HCl (pH 7.5), 150 m[m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} EDTA, 10 m[m]{.smallcaps} NEM, 0.5 m[m]{.smallcaps} AEBSF, and Protease Inhibitor Mixture Tablet (Roche). Lysates were clarified by centrifugation (14,200 rpm for 20 min in an Eppendorf Centrifuge 5417R) and bound to 30 μl of TUBE2 agarose beads (Boston Biochem, Cambridge, MA)/5--10 mg lysate for 2--3 h with rotation at 4 °C. Beads were washed three times with lysis buffer and an equal volume of 2X SDS-PAGE buffer was added before boiling the beads for 5 min to elute conjugates. Boiled aliquots were resolved by SDS-PAGE and immunoblotted.

#### Quantitative Reverse Transcription PCR

RNA was isolated from 3 OD~600~ units of cells using Trizol (Invitrogen) according to the manufacturer\'s recommendations. cDNA was prepared using the Superscript first strand synthesis kit (Invitrogen) and quantitative PCR was performed using the SYBR GreenER super mix (Invitrogen) with primers described in [supplemental Table S5](http://www.mcponline.org/cgi/content/full/M113.030163/DC1).

#### Immunoblot Analysis

Cell pellets were first boiled for 3 min and then after the addition of SDS-PAGE buffer supplemented with 5 m[m]{.smallcaps} NEM and glass beads, lysed by vortexing in a Fast Prep-24 (MP) for 1 min at a setting of 6.5 and boiled again for 3 min. Boiled lysates were centrifuged at 16,000 × *g* for 5 min. Aliquots were resolved by SDS-PAGE, transferred to nitrocellulose, and stained with Ponceau S to determine equivalent loading of protein extracts. The nitrocellulose filters were immunoblotted with desired antibody and developed by ECL or SuperSignal (Invitrogen). For detecting ^myc^Spt23^V5^, ^myc^Spt23^HA^, and ^myc^Mga2, anti-myc (Covance), anti-V5 (Invitrogen), and anti-HA (16B12, Roche) antibodies were used at a dilution of 1:3000. Other immunoblots were performed with antibodies specific for Ubiquitin (Stressgen Biotechnologies, Victoria, BC, Canada) dilution 1:1000, Dpm1 (Invitrogen) dilution 1:3000, tubulin (Santa Cruz, Santa Cruz, CA) dilution 1:30000, TAP tag (Thermo Scientific) dilution 1:3000, Rsp5 (gift from Linda Hicke) dilution 1:3000, Cdc48 (gift from Thomas Sommer and Ernst Jarosch) dilution 1:1000, and Ufd1 (custom polyclonal antibody from Covance) dilution 1:10000.

#### Growth Assays

For plating assays cells were grown in YPD or SRaffinose-URA and diluted to OD~600~ of 0.3 in water. Serial fivefold dilutions were prepared in water and spotted onto YPD ± 0.2% oleic acid or minimal medium plates supplemented with various additives as described in the text. Plates were incubated at 30 °C or 37 °C for 2--4 days.

#### Turnover of Spt23

RJD 6138, 6139, and 6167 cells were grown in YPD to an OD~600~ ∼1.0, at which point 100 μg/ml cycloheximide was added to initiate a chase. Samples were taken at the time points indicated. To monitor Spt23 following the switch from medium containing oleic acid to medium lacking oleic acid, cells were grown in YPD + 0.2% oleic acid, washed in water, and resuspended in YPD supplemented with cycloheximide. Proteins were extracted as described in the Immunoblot Analysis section with boiling SDS-PAGE buffer supplemented with 5 m[m]{.smallcaps} NEM. Lysates were resolved by SDS-PAGE and immunoblotted.

#### Immunoprecipitation of Ubx2

RJD 3166, 6172, 6173, and 4614 were grown in YP plus 2% galactose (to induce expression of ^myc^Spt23^HA^ from the *GAL* promoter) to an OD~600~ ∼1.0, harvested, and flash-frozen in liquid nitrogen. Cells were lysed by grinding in liquid nitrogen. Frozen cell powder was resuspended in lysis buffer containing 50 m[m]{.smallcaps} Tris (pH 7.5), 100 m[m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} EDTA, 5 m[m]{.smallcaps} Mg(OAc)~2~, 0.2% Triton X-100, 5 m[m]{.smallcaps} NEM, and Protease Inhibitor Mixture Tablet (Roche), clarified by centrifugation (14,200 rpm for 20 min on an Eppendorf Centrifuge 5417R) and bound to rabbit IgG conjugated to superparamagnetic Dynabeads (Invitrogen) for 3 h with mixing at 4 °C. Beads were washed three times with lysis buffer and bound proteins were eluted by boiling in SDS-PAGE buffer and resolved by SDS-PAGE before immunoblotting.

#### Immunofluorescence

RJD 6172 and 6182 cells were grown in YP plus 2% galactose (to induce expression of ^myc^Spt23^HA^ from the *GAL* promoter) to an OD~600~ ∼0.5--1.0. Cell cultures were adjusted to 4% formaldehyde and incubated for 15 min before cells were collected, washed, and spheroplasted by treatment with 50 units of lyticase (Sigma) for 10 min. Spheroplasts were washed and placed on ConA-coated glass slides. Cells were permeabilized with methanol and acetone washes. Cells were treated with blocking buffer (2% BSA, 0.1% Tween20 in PBS) and incubated with primary antibody overnight at a dilution of 1:1000. FITC-conjugated secondary antibody was added and cells were incubated for another hour followed by DNA staining with DAPI. Mounting medium was placed on cells and images were taken with a Zeiss confocal microscope with a 100× objective.

RESULTS
=======

### 

#### Identification and Quantification of Changes in the Ubiquitin Proteome

To better understand the breadth of function of Cdc48 and its adaptors that contain an UBX domain, we sought to identify ubiquitin conjugates whose levels increased in yeast cells deficient in these components. The rationale underlying this approach is based on the observation that ubiquitinated Rpb1 substrate accumulates in *ubx5*Δ and *cdc48-3* cells ([@B18]). Wild type and mutant yeast cells expressing His8-tagged ubiquitin were labeled with heavy and light lysine and arginine, respectively, and immediately before harvesting and lysis the cultures were mixed. Ubiquitin conjugates were purified on Ni^2+^-NTA magnetic beads under denaturing conditions (8 [m]{.smallcaps} urea) and digested with trypsin. The resulting peptides were subjected to strong anionic exchange (SAX) fractionation before sequencing in a mass spectrometer ([Fig. 1](#F1){ref-type="fig"}*A*). We performed this analysis in triplicate with *cdc48-3* and in duplicate with six of the seven *ubx*Δ mutant strains (*ubx2*Δ-*ubx7*Δ; *shp1*Δ/*ubx1*Δ was not analyzed because it grew so poorly).

![**Sequencing and quantification of the ubiquitin proteome reveals proteins regulated by Cdc48 and its UBX domain adaptors.** *A*, Experimental workflow for identification and quantification of Ub conjugates. Proteins were quantified using the SILAC method. Light (WT) and heavy (mutant) isotope labeled cells constitutively expressing ^His8^Ub were grown, collected in log-phase, and mixed. The cells were lysed in denaturing urea buffer and ubiquitinated proteins were purified with nickel-NTA magnetic beads. Proteins were digested into peptides, which were fractionated via strong anionic exchange and analyzed by mass spectrometry. *B*, Smoothed histogram depicting changes in the ubiquitinated proteome in mutants. *C*, Heatmap of relative changes to the ubiquitin proteome in various mutants. Only proteins that exhibited a significant change from a 1:1 ratio (mutant/wild type) in at least one experiment are colored. Abundance changes were deemed significant if the mutant/wild type ratio deviated from 1:1 with a *p* value less than .05 corrected for multiple hypothesis testing by the Benjamini and Hochberg method ([@B44]). *D*, Graphical representation of how frequently an ubiquitin conjugate found to accumulate in the query mutant also accumulated in other mutants.](zjw0101345510001){#F1}

To evaluate the reproducibility of our methodology we compared biological replicates ([supplemental Figs. S1*A*, S1*B*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)), which revealed that our data sets were highly correlated and demonstrated low coefficients of variation. To improve further the quality of our proteomic data set, we performed two separate control experiments, the results of which were used to computationally filter our data before further analysis. In the first experiment both the light and heavy-labeled cultures were wild type. This analysis yielded a narrow distribution of heavy/light ratios centered on 2^0^, confirming the significance of the broader ratio distributions seen in the wild type/mutant comparisons ([Fig. 1](#F1){ref-type="fig"}*B*, [supplemental Fig. S2*A*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). Proteins that exhibited ratios that deviated from 2^0^ by \>10% (*p* value \<0.01) in this control experiment were excluded from our overall data set. In the second control, we compared untagged, light-labeled cells and ^His8^Ub-expressing heavy-labeled cells. Proteins that were significantly enriched in the ^His8^Ub-expressing cells (*p* value\<0.05) were deemed to be derived from bona fide ubiquitin conjugates. After computational filtration, our data set contained ratios (ranging between 0.018 and 53.3) for 1916 ubiquitinated proteins identified and quantified at least once and 1733 ubiquitinated proteins identified in at least one replicate of each mutant/wild type comparison (all proteins identified are listed in [supplemental Table S1](http://www.mcponline.org/cgi/content/full/M113.030163/DC1), [supplementary File S1 and S2](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). In the *ubx2*Δ (1, 677), *ubx3*Δ (1, 701), *ubx4*Δ (1, 707), *ubx5*Δ (1, 581), *ubx6*Δ (1, 683), and *ubx7*Δ (1, 625) experiments the indicated number of proteins (out of 1733 possible) were identified in both replicates. In the *cdc48-3* experiments, 1588 of the 1733 proteins were identified in triplicate. We additionally identified 67 di-glycine peptide signatures, which are indicative of ubiquitination sites; 25 of the 67 were previously identified ([supplemental Table S2, supplementary File S3 and S4](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). The proteins in this study covered over 50% of the previously identified ubiquitinated proteins in the SCUD (<http://scud.kaist.ac.kr/>) and included 1226 proteins not previously listed ([supplemental Fig. S2*B*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). These metrics suggest that we have sampled a substantial portion of the ubiquitinated proteome.

#### UBX Proteins Target Different Subsets of Ubiquitin Conjugates

From the initial screen it was evident that *cdc48-3* and *ubx*Δ mutations had wide-ranging and variable effects on the ubiquitin proteome. Comparison of the ratio distributions of the different experiments underscores this conclusion ([Fig. 1](#F1){ref-type="fig"}*B*). Consistent with Cdc48 being the hub of its eponymous network, *cdc48-3* had the greatest effect on the ubiquitinated proteome. Twenty-six percent of ubiquitin conjugates were detected at higher levels in *cdc48-3* compared with wild type cells whereas 17% were decreased in amount. We do not know the reason for the latter but it could be because of reduced expression of the protein or increased competition for free ubiquitin, because total conjugated ubiquitin increases substantially in *cdc48-3* cells ([@B18]). Among the *ubx*Δ mutants *ubx5*Δ and *ubx6*Δ caused the strongest perturbations; by contrast *ubx3*Δ had the least effect, followed by *ubx4*Δ. To evaluate the impact of the *cdc48-3* and *ubx*Δ mutations with more granularity, we generated a heatmap that captures the behavior of the changing conjugates quantified in all experiments in our data set ([Fig. 1](#F1){ref-type="fig"}*C*). Three important points are evident in this graphic. First, *ubx6*Δ and *ubx7*Δ displayed remarkable overlap with over 85% of the ubiquitin conjugates accumulating in *ubx7*Δ also accumulating in *ubx6*Δ. Very little is known about Ubx6 and Ubx7 but this result is consistent with their close homology and colocalization at the perinuclear membrane ([@B45]). Second, *cdc48-3* mutants accumulated a set of ubiquitin conjugates (128 proteins) that did not accumulate in any single *ubx*Δ mutant. This suggests that many substrates may engage Cdc48 without an Ubx protein, and could explain why a relatively low fraction of Cdc48/p97 substrates have been shown to be dependent on an UBX domain cofactor. Third, with the exception of *ubx6*Δ and *ubx7*Δ, the different mutations had markedly different effects on the ubiquitin conjugate proteome. This conclusion was also supported by an independent analysis ([Fig. 1](#F1){ref-type="fig"}*D*), which indicated that for each *ubx*Δ mutant except *ubx6*Δ and *ubx7*Δ, \>40% of the accumulating conjugates were elevated only in that mutant and up to ∼90% were elevated in that mutant and at most one other mutant. This supports the hypothesis that individual Ubx proteins target distinct sets of ubiquitin conjugates, which is consistent with their proposed role as substrate adaptors for the Cdc48 engine. Remarkably, of the 1733 proteins in our data set, 62% were elevated significantly in at least one mutant (62% was highly significant in comparison to the null hypothesis in which peptide ratios are randomly assigned to proteins (*p* value \< 1e-100)), suggesting that the Cdc48 network has a profound impact on the UPS that is greater than has been previously appreciated.

#### Ubiquitin Conjugates that are Elevated in Different ubxΔ Mutants Map to Diverse Cellular Components and Cellular Processes

To understand the subcellular localization and functions of the ubiquitinated species identified in our analyses, we evaluated Yeast GO-Slim cell components and GO-Slim biological process annotations ([Figs. 2](#F2){ref-type="fig"}*A* and [2](#F2){ref-type="fig"}*B*). Many different trends were apparent from this analysis. Ubiquitin conjugates that were elevated in *cdc48-3* cells (referred to hereafter as "*cdc48-3* conjugates") encompassed numerous known targets including Mga2 and Spt23 ([@B24], [@B28]), the HMG-CoA reductases Hmg1 and Hmg2 ([@B46]), and the Rpb1 subunit of RNA Polymerase II ([@B18]). Consistent with the known roles of Cdc48 in membrane biology, *cdc48-3* conjugates were significantly enriched for proteins of the endomembrane system including the ERP and ERV family of proteins involved in ER to Golgi transport, members of the GPI family of proteins, subunits of the Golgi mannosyltransferase complex, and all seven proteins of the PMT (Protein o-mannosyltransferase) family. The *cdc48-3* conjugates were also enriched for glycosylated proteins, enzymes of lipid and carbohydrate metabolism, and proteins involved in nuclear pore complex, nuclear organization, stress response, and the ubiquitin-proteasome system ([supplemental Fig. S3*A*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). Further investigation of the latter category revealed that *cdc48-3* cells contained elevated levels of ubiquitin conjugated species of multiple E3 ubiquitin ligases and F-Box proteins ([supplemental Fig. S3*B*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). This is consistent with recent identification of Cdc48 as an SCF^Met30^ disassembly factor ([@B47]) and suggests that Cdc48 may be more widely involved in regulation of SCF complexes.

![**Changes to the ubiquitin conjugate proteome in *ubx*Δ mutants suggest functional specialization of Ubx proteins.** *A*, Overview of how ubiquitin conjugates that accumulate in *cdc48-3* and *ubx*Δ mutants are distributed according to GO-Slim cell components and (*B*) GO-Slim biological processes. All of the proteins analyzed in (*A*) and (*B*) demonstrated enrichment greater than 10% (with ≥95% confidence) in one or more mutants. *C*, Box and whisker plot of annotation terms demonstrating a significant enrichment in the Ub-Proteome for a majority of their identified members in the *ubx2*Δ mutant strain. Significance was calculated based on the 25 percentile of the distribution of protein ratios of protein annotated with the term in comparison to all *ubx2*Δ ratios. Enriched GO Cellular Component (CC), GO Biological Process (BP), GO Molecular Function (MF), and Uniprot Keyword (KW) terms are shown.](zjw0101345510002){#F2}

Analysis of the ubiquitin conjugates that were elevated in *ubx2*Δ relative to wild type cells (*i.e. ubx2*Δ conjugates) indicated there was a significant enrichment of vacuolar and metabolic transport proteins, including secretory proteins ([Fig. 2](#F2){ref-type="fig"}*A*--[2](#F2){ref-type="fig"}*C*). Many of these proteins are synthesized in the ER, where Ubx2 is localized. Notably, elevated levels of ubiquitinated forms of a number of ER proteins were detected in both *ubx2*Δ and *cdc48-3* cells, including members of the ergosterol biosynthesis pathway and the *OLE1* transcription factors Spt23 and Mga2, consistent with a role for Ubx2-Cdc48 in regulating lipid metabolism.

Deletion of *UBX3* had little impact on the ubiquitin conjugate proteome with no proteins changing consistently in a significant manner. The pool of *ubx4*Δ conjugates was likewise small but was enriched for ER proteins involved in lipid metabolism including Spt23, Mga2, Hmg1, and Hmg2 ([Figs. 2](#F2){ref-type="fig"}*A*, [2](#F2){ref-type="fig"}*B*, [supplemental Fig. S4*A*, S4*B*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)).

Ubiquitin conjugates that were elevated in *ubx5*Δ cells were enriched for vacuolar and plasma membrane proteins, including proteins involved in ion and amino acid transport such as the TPO family of proteins involved in polyamine transport ([Fig. 2](#F2){ref-type="fig"}*A*, [2](#F2){ref-type="fig"}*B*, [supplemental Fig. S4*C*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). Ubx5 contains an UIM domain that links it to Rub1-conjugated cullin-RING ubiquitin ligases (CRLs) ([@B48], [@B49]), raising the possibility that a CRL regulates trafficking of membrane proteins in yeast.

Lastly, ubiquitin conjugates that were elevated in *ubx6*Δ and *ubx7*Δ were highly enriched for nucleolar and ribosomal proteins, including proteins involved in ribosome assembly ([Fig. 2](#F2){ref-type="fig"}*A*, [2](#F2){ref-type="fig"}*B*, [supplemental Fig. S4*D*, S4*E*](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). In agreement with a nuclear and nucleolar function, Ubx6 and Ubx7 localize to the nuclear periphery and nucleus ([@B45]).

#### Ubiquitinated Spt23 and Mga2 Accumulate in ubx2Δ

The increase in ubiquitinated Spt23 and Mga2 species in *cdc48-3*, *ubx2*Δ and *ubx4*Δ cells ([Fig. 3](#F3){ref-type="fig"}*A*) piqued our interest because although it was already known that Cdc48-Ufd1-Npl4 promotes release of Spt23 and Mga2 from the ER membrane and ubiquitinated forms of these transcription factors accumulate in *cdc48*, *npl4*, and *ufd1* cells ([@B24], [@B25], [@B28], [@B31]), Ubx proteins had not previously been implicated in this pathway. To evaluate the ubiquitination status of Spt23 in *ubx2*Δ and *ubx4*Δ mutants, we first generated a yeast strain in which endogenous *SPT23* was modified to express proteins bearing an N-terminal myc tag and C-terminal V5 tag (^myc^Spt23^V5^). We then used Ni^2+^-NTA magnetic beads to purify ubiquitin conjugates from *^myc^SPT23^V5^* strains expressing His8-tagged ubiquitin. Immunoblotting for tagged Spt23 revealed robust accumulation of high molecular weight conjugates in both *ubx2*Δ and *ubx4*Δ as compared with wild type ([Fig. 3](#F3){ref-type="fig"}*B*). For reasons we do not understand, overexpression of ^His8^Ub altered accumulation of ubiquitin conjugates on ^myc^Spt23^V5^; in the presence of ^His8^Ub *ubx4*Δ accumulated more ubiquitinated ^myc^Spt23^V5^ than *ubx2*Δ whereas in the absence of ^His8^Ub the reverse was observed (*e.g.* [Fig. 5](#F5){ref-type="fig"}*A*, [5](#F5){ref-type="fig"}*B*). To evaluate the ubiquitination status of Mga2 in *ubx2*Δ and *ubx4*Δ mutants, we used Tandem Ubiquitin Binding Entity (TUBE2) beads to purify endogenous ubiquitin conjugates from strains transformed with a plasmid that expressed Mga2 with a myc tag appended to its N terminus (^myc^Mga2). Immunoblotting for ^myc^Mga2 revealed an accumulation of high molecular weight conjugates in *ubx2*Δ cells compared with wild type ([supplemental Fig. S5](http://www.mcponline.org/cgi/content/full/M113.030163/DC1)). By contrast, few if any high MW ubiquitin conjugates of Mga2 were detected in *ubx4*Δ cells.

![**Ubiquitin-conjugated forms of Spt23 and Mga2 accumulate in *ubx2*Δ cells.** *A*, Table of Spt23 and Mga2 SILAC ratios in *ubx2*Δ:WT and *ubx4*Δ:WT comparisons. The reported ratios incorporate many independent measurements (Spt23 *ubx2*Δ: 7, *ubx4*Δ: 24; Mga2 *ubx2*Δ: 21, *ubx4*Δ: 37). *B*, Validation of Spt23 ubiquitin conjugate accumulation. Ubiquitin conjugates in WT, *ubx2*Δ, and *ubx4*Δ cells expressing ^myc^Spt23^V5^ from the natural locus and ^His8^Ub from a plasmid were purified with nickel-NTA magnetic beads. The input extract and bound fractions were immunobloted for the myc epitope, Ub, and tubulin (input loading control) as indicated.](zjw0101345510003){#F3}

#### Ubx2 is a Component of the OLE1 Pathway

In rapidly growing cells that are producing lipids for membrane assembly, the transmembrane p120 forms of Spt23 and Mga2 are ubiquitinated by the ubiquitin ligase Rsp5 and cleaved by the proteasome ([@B23]). Subsequently, Cdc48-Ufd1-Npl4 promotes release of cleaved p90 forms of Spt23 and Mga2 from the ER membrane, allowing these proteins to translocate to the nucleus where they activate transcription of *OLE1*, which encodes the essential enzyme that generates UFAs ([@B26]). The accumulation of ubiquitin-conjugated Spt23 and Mga2 in *ubx2*Δ raised the question of whether Ubx2 also functions in this pathway. To address this question we first tested for genetic interactions between *rsp5-1* and *ubx*Δ mutants. Similar to the previously reported synthetic lethality of *cdc48* and *ufd1* with *rsp5* ([@B24]), *ubx2*Δ *rsp5-1* cells failed to grow on YPD at 30 °C but were rescued by addition of the UFA oleic acid ([Fig. 4](#F4){ref-type="fig"}*A*). By contrast, *ubx4*Δ *rsp5-1* did not exhibit synthetic lethality. To test more directly the hypothesis that Ubx2 promotes expression of *OLE1*, we measured *OLE1* mRNA levels in mutants grown in YPD. During normal log-phase growth in YPD, *ubx2*Δ cells showed a fivefold reduction in *OLE1* mRNA ([Fig. 4](#F4){ref-type="fig"}*B*). Moreover, as was previously reported for *rsp5* mutants ([@B23]), both *ubx2*Δ and *rsp5*Δ cells failed to accumulate *OLE1* mRNA on being shifted from a medium containing oleic acid to a medium lacking UFAs ([Fig. 4](#F4){ref-type="fig"}C). By contrast, *ubx4*Δ was not defective in *OLE1* regulation and did not exacerbate the effect of *ubx2*Δ ([Figs. 4](#F4){ref-type="fig"}*B*, [4](#F4){ref-type="fig"}*C*).

![**Ubx2 promotes inducible expression of *OLE1*.** *A*, Synthetic lethality of *rsp5-1* and *ubx2*Δ mutations. Fivefold serial dilutions of WT, *rsp5-1*, *ubx2*Δ, *ubx4*Δ, *rsp5-1 ubx2*Δ, and *rsp5-1 ubx4*Δ cells were plated on YPD and YPD+0.2% oleic acid and incubated at 30 °C or 37 °C for 2 days. *B*, *C*, Expression of *OLE1* mRNA in *ubx2*Δ cells grown in YPD (*B*) or grown first in YPD +0.2% oleic acid and shifted to YPD for two hours (*C*). RNA from cells grown to log-phase in YPD medium was used for RT-qPCR to assess *OLE1* mRNA levels. Values were normalized to *ACT1*. Error bars denote S.D.; *n* = 2. *D*, Toxicity because of Spt23 and Mga2 overexpression is suppressed by *ubx2*Δ. WT, *ubx2*Δ, and *ubx4*Δ strains transformed with a 2 μm plasmid that contains either *GAL-SPT23* or *GAL-MGA2* were plated onto YPD and synthetic dextrose- or galactose- containing media and grown for 4 days at 30 °C.](zjw0101345510004){#F4}

The results above suggested that Ubx2 is involved in activation of Spt23 and Mga2. As further confirmation, we examined the effect of Spt23 and Mga2 overexpression in mutant cells ([Fig. 4](#F4){ref-type="fig"}*D*). Although UFAs are required for survival, the excess production of oleic acid that occurs on hyperactivation of *OLE1* expression is toxic ([@B50]). Whereas overexpression of Spt23 or Mga2 from a galactose-inducible promoter inhibited growth of wild type cells, *ubx2*Δ cells, like *rsp5-1* cells ([@B51]), were more tolerant ([Fig. 4](#F4){ref-type="fig"}*D*), even though they equally overexpressed these *OLE1* activators (data not shown).

#### Ubx2 Regulates Processing of Spt23

We next wanted to determine if Ubx2 is involved in processing of the *OLE1* activators from their p120 precursor forms to their p90 active forms. For these experiments we focused on Spt23 because we found it difficult to consistently detect tagged Mga2 expressed from its endogenous locus. We examined steady state levels of ^myc^Spt23^V5^ in YPD-grown cells deficient in various components of the Cdc48 and proteasome pathways ([Fig. 5](#F5){ref-type="fig"}*A*). As anticipated from prior results ([@B24]), the *cim3-1* and *rsp5-1* mutants exhibited a severe defect in p90 accumulation ([Fig. 5](#F5){ref-type="fig"}*A*, [5](#F5){ref-type="fig"}*B*; *cim3-1* is a temperature-sensitive allele of the gene that encodes proteasome subunit Rpt6). Notably, p90 accumulation was also significantly impaired in *cdc48-3* and *ufd1-2* strains. In *ubx2*Δ ([Fig. 5](#F5){ref-type="fig"}*A*, [5](#F5){ref-type="fig"}*B*) but not in other *ubx*Δ mutants ([Fig. 5](#F5){ref-type="fig"}*B*), ubiquitinated high MW forms of ^myc^Spt23^V5^ accumulated and the p90:p120 ratio was significantly reduced. However, the degree to which processing to p90 was defective varied in different experiments. In the prevailing model, Cdc48-Ufd1-Npl4 acts primarily after the proteasome to promote release of p90 from the ER membrane ([@B24], [@B31], [@B52]). However, it has also been reported that Cdc48-Ufd1-Npl4 is required for processing of p120 to p90 ([@B25]). Our data are consistent with those of Hitchcock *et al.* and suggest that Cdc48-Ufd1 and Ubx2 make important contributions to efficient formation of p90.

![**Ubx2 regulates processing and stability of the transcription factor Spt23.** *A*, Steady-state level of Spt23 in *OLE1* pathway mutants. The indicated mutant strains expressing ^myc^Spt23^V5^ from the endogenous locus were grown in YPD at 30 °C (*ubx2*Δ, *ubx4*Δ, and *npl4-1*) and 37 °C (*cdc48-3*, *ufd1-2*, *cim-3*, and *rsp5-1*). Cell lysates were fractionated by SDS-PAGE and immunoblotted with anti-myc, anti-V5, and anti-tubulin antibodies. *B*, Steady-state levels of Spt23 in *ubx*Δ mutants. The indicated strains were grown in YPD at 30 °C (except for *cim3--1* at 37 °C) and analyzed as in (*A*). *ubx2/4*Δ indicates an *ubx2*Δ *ubx4*Δ double mutant. *C*, Influence of Ubx2\'s UBA and UBX domains on the steady-state level of Spt23. Same as (*A*) except that strains in lanes 2--6 were *ubx2*Δ bearing a copy of full-length (FL) *UBX2* or a version lacking the indicated domain integrated at *LEU2. D*, Effect of UFAs on modification and processing of Spt23 in various mutants. Same as (*A*) except that strains were grown in normal medium or medium supplemented with 0.2% oleic acid as indicated. Cells were grown at 30 °C (*ubx2*Δ) and 37 °C (*cdc48-3*). *E*, Role of Ubx2 and Cdc48 in p90 degradation. Wild type, *ubx2*Δ, and *cdc48-3* cells expressing ^myc^Spt23^V5^ from the endogenous locus were grown in YPD at 30 °C (*left* panel) or at 25 °C followed by a shift to 37 °C for 2 h (*right* panel) before addition of cycloheximide to initiate a chase. At the indicated times (minutes) cells were harvested and processed for SDS-PAGE followed by immunoblotting with anti-myc, or anti-tubulin antibodies.](zjw0101345510005){#F5}

After establishing a role for Ubx2 in Spt23 processing, we next investigated the contribution of its UBA and UBX domains to this reaction. We immunoblotted for ^myc^Spt23^V5^ in *ubx2*Δ strains in which full-length and various deletion mutants of *UBX2* were integrated at the *LEU2* locus under control of the *UBX2* promoter ([@B53]) ([Fig. 5](#F5){ref-type="fig"}*C*). This experiment confirmed that the defect in Spt23 processing in *ubx2*Δ cells was because of lack of Ubx2, and suggested that the UBX domain played a more important role in processing than the UBA domain. RT-PCR analysis of these same strains grown in oleic acid and switched to oleic acid-free medium revealed a large decrease in *OLE1* mRNA induction in the UBAΔ UBXΔ mutant but not the single mutants (data not shown).

Ubx2 is orthologous to human Ubxd8, which may directly sense UFAs ([@B54], [@B55]). We therefore tested whether Ubx2 was required to sense UFAs in yeast. To address this question we grew wild type and mutant cells with and without oleic acid and evaluated processing of ^myc^Spt23^V5^. We reasoned if Ubx2 is required to sense UFAs, that the reduced level of p90 formed in *ubx2*Δ would be insensitive to their presence. Processing of ^myc^Spt23^V5^ in wild type cells was strongly repressed by addition of oleic acid ([Fig. 5](#F5){ref-type="fig"}*D*). Likewise, the residual formation of p90 observed in *cim3-1*, *cdc48-3*, and *ubx2*Δ cells remained sensitive to inhibition by oleic acid. Consistent with this, our analysis of *OLE1* mRNA revealed that although its levels were severely reduced in *ubx2*Δ and *ubx2*Δ *ubx4*Δ, they were diminished further on addition of oleic acid ([Fig. 4](#F4){ref-type="fig"}*C*). Taken together, these data indicate that there must be at least one UFA sensor that remained in *ubx2*Δ cells. Careful inspection of the modification state of ^myc^Spt23^V5^ in *cdc48-3* and *ubx2*Δ cells grown with or without oleic acid suggested that sensing of UFAs occurred at or before Rsp5-dependent ubiquitination ([Fig. 5](#F5){ref-type="fig"}*D*).

To investigate in greater depth the role of Ubx2 in Spt23 processing, we performed cycloheximide chase experiments ([Fig. 5](#F5){ref-type="fig"}*E*). The p90 form of ^myc^Spt23^V5^ was rapidly degraded in wild-type but was modestly stabilized in *ubx2*Δ and strongly stabilized in *cdc48-3* cells. By contrast, p120 was more stable than p90 in all conditions whereas the high MW ubiquitin conjugates that accumulated in *ubx2*Δ and *cdc48-3* were rapidly metabolized. Given that: (1) p90 was unstable in wild type, (2) more than half of ^myc^Spt23^V5^ detected at zero-time in wild type was processed to p90, and (3) conversion of p120 to p90 was very slow and inefficient, we suggest that in wild type cells grown at 30 °C p120 became conjugated with ubiquitin and rapidly processed to p90 either during or very shortly after completion of synthesis, such that newly synthesized molecules that escaped modification were largely refractory to subsequent processing.

#### Ubx2 Associates with Spt23 and affects its Subcellular Localization

To test whether the effects of *ubx2*Δ on Spt23 were likely to be direct, TAP-tagged Ubx2 was immunoprecipitated from cells and immunoblotted for associated proteins ([Fig. 6](#F6){ref-type="fig"}*A*). This experiment revealed a direct interaction between Ubx2 and unmodified p120 as well as higher MW ubiquitinated ^myc^Spt23^HA^. Additionally, as expected ([@B33]), Cdc48 and Ufd1 were detected at levels above background in the Ubx2^TAP^ immunoprecipitate, as was Rsp5, which had not previously been shown to interact with Ubx2.

![**Ubx2 interacts with Spt23 and influences its subcellular localization.** *A*, Ubx2 directly interacts with Spt23 and Rsp5. RJD 6173 cells expressing Ubx2^TAP^ from the natural locus were grown at 30 °C in YP plus 2% galactose to induce expression of Spt23. Native cell lysates were subjected to anti-TAP immunoprecipitation (IP) and the immunoprecipitates and input lysates were immunoblotted (IB) for TAP, ^myc^Spt23^HA^, Cdc48, Ufd1, and Rsp5. Input extracts were also blotted for tubulin. *B*, Immunofluorescence localization of Spt23 in WT and *ubx2*Δ cells. WT (RJD 6172) and *ubx2*Δ (RJD 6182) cells expressing Spt23 from the *GAL* promoter were grown at 30 °C for 6 h in YP plus 2% galactose. All forms of Spt23 containing an intact N terminus were detected with anti-myc antibody and the nucleus was marked by staining DNA with DAPI. Nomarski optics (DIC) were used to identify the outline of each cell. *C*, Quantification of fraction of cell population with from (*B*) that contain Spt23 punctae. Seven fields of ∼300 cells were counted per strain. Error bars denote S.D.](zjw0101345510006){#F6}

To address the effect of *ubx2*Δ on subcellular localization of Spt23, we performed immunofluorescence on cells that expressed a pulse of ^myc^Spt23 from the *GAL1* promoter (attempts to detect ^myc^Spt23^V5^ expressed from the natural locus were unsuccessful). Consistent with our observation that Ubx2 was required for *OLE1* expression, ^myc^Spt23 demonstrated a decrease in localization to the nucleus in most *ubx2*Δ cells ([Fig. 6](#F6){ref-type="fig"}*B*). Additionally, in ∼45% of *ubx2*Δ cells, Spt23 was observed to accumulate in cytosolic punctae ([Fig. 6](#F6){ref-type="fig"}*C*). Although we do not understand their exact molecular nature, the existence of these punctae in *ubx2*Δ together with poor nuclear accumulation point to a role for Ubx2 in proper localization of Spt23.

DISCUSSION
==========

### 

#### The Cdc48 Network Plays a Broad Role in Shaping the Ubiquitin Conjugate Proteome

To address globally the impact of Cdc48 and its Ubx adaptors on the UPS, we evaluated changes to the ubiquitin conjugate proteome in yeast cells deleted for individual *UBX* genes or carrying a temperature-sensitive *cdc48-3* allele. Our findings support a broad role for the Cdc48 network in the UPS. Overall, we identified 1,916 putative ubiquitin conjugates and 1,733 were quantified in all experiments. Of the 1733, over 62% were found at statistically significant elevated levels relative to wild type in at least one of the mutant strains. Mutation of different *UBX* genes led to markedly distinct effects on the ubiquitin conjugate proteome. For example, our findings suggested novel and unexpected roles for Ubx2, Ubx5, and Ubx6/7 in regulation of vacuolar, plasma membrane, and nucleolar/ribosomal proteins, respectively. However, only a fraction of ubiquitin conjugates annotated with a given term were up-regulated in a particular *ubx*Δ mutant (*e.g.* not all ubiquitin-conjugated vacuolar proteins were found at increased levels in *ubx2*Δ). Thus, localization alone does not render a ubiquitin conjugate subject to regulation by a particular Ubx cofactor.

Our approach assumes that ubiquitin conjugates that are elevated in a particular mutant relative to wild type represent intermediates that accumulate on attenuation of Cdc48 activity or deletion of the adaptor that normally links them to Cdc48. However, increased levels of a conjugate may arise from increased expression of the protein. Of interest, numerous ubiquitin conjugates were selectively depleted in specific *ubx*Δ strains. This was not investigated further, but during the course of this work it was reported that the human UBX protein SAKS1 protects ERAD substrates from deubiquitination ([@B56]) and overproduced UBXD7 binds to and increases the fraction of Nedd8-conjugated Cul2 in human cells ([@B48], [@B49]). Hence, the large number of conjugate depletion events that we observed in *ubx*Δ cells may represent species whose ubiquitin-conjugated forms are stabilized on binding of Ubx proteins. Our extensive dataset provides a rich resource for future investigations into this and other questions related to the functions and regulation of the Cdc48 network.

#### Ubx2 and Cdc48 Promote Proteasome-Dependent Processing of Spt23

Prior work from the Jentsch and Haines laboratories emphasized a role for Cdc48-Ufd1-Npl4 in release of the processed forms of Spt23 ([@B24]) and Mga2 ([@B31]) from the ER membrane. By contrast, data from the Silver laboratory emphasized an upstream role for Cdc48-Ufd1-Npl4 in processing of both proteins ([@B25]). Our data support a role for Cdc48-Ufd1 and Ubx2 in both steps. We observe diminished levels of p90 in mutant cells. However, the reduced p90 accumulation in *ubx2*Δ is variable and is less striking than the defect in *OLE1* induction. We propose that Cdc48-Ufd1-Npl4-Ubx2 acts sequentially to promote both the processing of Spt23 p120 to p90, and localization of p90 to the nucleus. A prominent role for Cdc48-Ufd1 and Ubx2 in proteasome-dependent cleavage of p120 resonates with data on other Cdc48-proteasome substrates, which consistently place Cdc48/p97 function upstream of (or contemporaneous with) the proteasome. Sequential roles for Ubx2 in the formation and activation of p90 helps explain why *ubx2*Δ exhibits such a severe defect in *OLE1* regulation.

Consistent with the prior data on *rsp5* mutants ([@B24]), *ubx2*Δ cells are severely deficient in induction of *OLE1* expression and double mutants deficient in Ubx2 and Rsp5 activity fail to grow on normal medium at 30 °C but are rescued by the addition of oleic acid, pointing to a crucial role for Ubx2 in maintaining sufficient Ole1 activity to meet the cellular requirement for UFAs. An important and interesting question that remains unresolved is, how are levels of fatty acids sensed so that the cell maintains an appropriate ratio of SFAs:UFAs? Addition of exogenous UFAs suppresses processing of p120 to p90 by the Rsp5-Ubx2-Cdc48 pathway, which reduces expression of the desaturase enzyme encoded by *OLE1*. It was suggested in prior work that the human ortholog of Ubx2, UBXD8, directly senses UFAs ([@B54], [@B55], [@B57]). However, addition of UFAs suppresses accumulation of ubiquitinated Spt23 and further reduces the residual expression of *OLE1* in *ubx2*Δ, indicating that these cells retain the ability to sense UFAs. Thus, if Ubx2 is a fatty acid sensor, it cannot be the only sensor in the *OLE1* pathway. Very recently, it was reported that Ire1 serves as a sensor for membrane lipid saturation in mouse cells ([@B58]). Our data suggest that either Rsp5 itself or a step upstream of Rsp5-dependent ubiquitination must be capable of sensing UFAs.
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